Answers are grounded in this paper and cite their sources.
Microbiological analysis is a critical process to ensure the safety, efficacy, and quality of medicines and other health-related products. This analysis identifies and controls the presence of microorganisms that could compromise the final product’s integrity and pose risks to patients’ health. The presence of microorganisms in products can lead to severe consequences, such as infections in patients, product degradation, and economic losses for companies. International regulations, including Good Manufacturing Practices (GMP) and official pharmacopeias, set stringent requirements for microbiological analysis. This type of analysis is especially vital for sterile products like injectables and eye drops, where any contamination could pose significant risks. It also applies to non-sterile products, such as creams, tablets, and syrups and any medical devices to ensure microbial loads remain within acceptable limits. Intrauterine devices (IUDs) are small, reversible birth control devices inserted into the uterus to prevent pregnancy, with two main types: copper IUDs and hormonal IUDs, both highly effective and lasting for several years. Microbiological testing of intrauterine contraceptive devices (IUDs) is crucial to assess the risk of infection, particularly pelvic inflammatory disease (PID), and to identify potential pathogens associated with IUD use, with studies showing that IUDs can harbor biofilms and various microorganisms. The present review focused on the importance and advancements of Microbiological testing of intrauterine contraceptive devices. Also, various methods employed for the microbiological testing of IUD have been highlighted in this paper. Key-words: Microbiological Testing, Intrauterine, Contraceptive devices
No takes yet. Share an insight, caveat, or question.
Chaturvedi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: